Segui
Eugenio Uriarte
Eugenio Uriarte
Profesor de Química Medicinal, Universidad de Santiago de Compostela, Universidad Autónoma de Chile
Email verificata su uautonoma.cl
Titolo
Citata da
Citata da
Anno
Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity
F Borges, F Roleira, N Milhazes, L Santana, E Uriarte
Current medicinal chemistry 12 (8), 887-916, 2005
11982005
Chromone: a valid scaffold in medicinal chemistry
A Gaspar, MJ Matos, J Garrido, E Uriarte, F Borges
Chemical reviews 114 (9), 4960-4992, 2014
6982014
Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices
H Gonzalez-Diaz, S Vilar, L Santana, E Uriarte
Current topics in medicinal chemistry 7 (10), 1015-1029, 2007
3732007
Recent advances on the role of topological indices in drug discovery research
E Estrada, E Uriarte
Current Medicinal Chemistry 8 (13), 1573-1588, 2001
3432001
Proteomics, networks and connectivity indices
H González‐Díaz, Y González‐Díaz, L Santana, FM Ubeira, E Uriarte
Proteomics 8 (4), 750-778, 2008
3072008
Hesperidin as a neuroprotective agent: a review of animal and clinical evidence
M Hajialyani, M Hosein Farzaei, J Echeverría, SM Nabavi, E Uriarte, ...
Molecules 24 (3), 648, 2019
2752019
Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes
J Leiro, E Alvarez, JA Arranz, R Laguna, E Uriarte, F Orallo
Journal of Leucocyte Biology 75 (6), 1156-1165, 2004
2502004
Coumarins—an important class of phytochemicals
MJ Matos, L Santana, E Uriarte, OA Abreu, E Molina, EG Yordi
Phytochemicals-isolation, characterisation and role in human health 25, 533-538, 2015
2432015
Antioxidant and pro-oxidant effects of polyphenolic compounds and structure-activity relationship evidence
EG Yordi, EM Pérez, MJ Matos, EU Villares
Nutrition, well-being and health 2, 23-48, 2012
2392012
Drug—drug interaction through molecular structure similarity analysis
S Vilar, R Harpaz, E Uriarte, L Santana, R Rabadan, C Friedman
Journal of the American Medical Informatics Association 19 (6), 1066-1074, 2012
2282012
Furocoumarins in medicinal chemistry. Synthesis, natural occurrence and biological activity
L Santana, E Uriarte, F Roleira, N Milhazes, F Borges
Current medicinal chemistry 11 (24), 3239-3261, 2004
2272004
Similarity-based modeling in large-scale prediction of drug-drug interactions
S Vilar, E Uriarte, L Santana, T Lorberbaum, G Hripcsak, C Friedman, ...
Nature protocols 9 (9), 2147-2163, 2014
2242014
A novel approach for the virtual screening and rational design of anticancer compounds
E Estrada, E Uriarte, A Montero, M Teijeira, L Santana, E De Clercq
Journal of medicinal chemistry 43 (10), 1975-1985, 2000
2232000
Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin–resveratrol hybrids
S Vilar, E Quezada, L Santana, E Uriarte, M Yánez, N Fraiz, C Alcaide, ...
Bioorganic & Medicinal Chemistry Letters 16 (2), 257-261, 2006
2022006
A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins
L Santana, E Uriarte, H González-Díaz, G Zagotto, R Soto-Otero, ...
Journal of medicinal chemistry 49 (3), 1149-1156, 2006
1892006
Potential pharmacological uses of chalcones: a patent review (from June 2011–2014)
MJ Matos, S Vazquez-Rodriguez, E Uriarte, L Santana
Expert opinion on therapeutic patents 25 (3), 351-366, 2015
1672015
Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors
MJ Matos, C Teran, Y Perez-Castillo, E Uriarte, L Santana, D Vina
Journal of medicinal chemistry 54 (20), 7127-7137, 2011
1672011
Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors
A Gaspar, T Silva, M Yánez, D Vina, F Orallo, F Ortuso, E Uriarte, S Alcaro, ...
Journal of medicinal chemistry 54 (14), 5165-5173, 2011
1652011
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure–activity relationships
A Chilin, R Battistutta, A Bortolato, G Cozza, S Zanatta, G Poletto, ...
Journal of medicinal chemistry 51 (4), 752-759, 2008
1642008
A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors
MJ Matos, D Viña, E Quezada, C Picciau, G Delogu, F Orallo, L Santana, ...
Bioorganic & medicinal chemistry letters 19 (12), 3268-3270, 2009
1552009
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20